Stock EDIT EDITAS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
4.67 USD -1.48% Intraday chart for Editas Medicine, Inc. -8.61% -53.90%
06-14 Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial MT
06-14 Editas Medicine, Inc. Reports New Safety and Efficacy Data from the Rubber Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association Annual Congress CI
c0e.Qt3ol8KUd4-0S-vj25Io7PkxcdDmG5dF5_QrWszM4sY.AIms34TuT97sOaib9tcap7wCPJO0ceEhrYFNKIP7r4Qpl6Pe79Ugv-cmgA~8855bf84d900d5ccb8901bdf80d41c97
  1. Stock Market
  2. Equities
  3. EDIT Stock
  4. Charts Editas Medicine, Inc.
  5. News Chart